NPACT- Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase
a

Compound: Eriodictyol

TargetsGene NameGene IDCancerCell LinesIC50ED50EC50GI50RemarkReferences
RPS6KA3ribosomal protein S6 kinase, 90kDa, polypeptide 36197preneoplastic epidermal keratinocytesJB6 C141----Docking experiments using the crystal structure of the RSK2 N-terminal kinase domain combined with in vitro pulldown assays demonstrated that eriodictyol, bound with the N-terminal kinase domain of RSK2 to inhibit RSK2 N-terminal kinase activity. RSK2-ATF1 signaling plays an important role in neoplastic cell transformation and that eriodictyol is a novel natural compound for suppressing RSK2 kinase activity21098035

 






Copyright © 2012. Subhash M. Agagrwal. All Rights Reserved.